Dementia and Geriatric Cognitive Disorders

Original Research Article

Prevalence, Resource Utilization and Costs of Vascular Dementia Compared to Alzheimer’s Dementia in a Population Setting

Sicras A.a · Rejas J.b · Arco S.c · Flores E.d · Ortega G.e · Esparcia A.e · Suárez A.c · Gordillo M.J.d

Author affiliations

aBadalona Serveis Assistencials SL, Badalona, Barcelona, bHealth Outcomes Research, Medical Unit, Pfizer SA, Alcobendas, Madrid, cPrimary Care Health Center Apenins-Montigalà, Badalona, Barcelona, dPrimary Care Health Center Morera-Pomar, Badalona, Barcelona, and ePrimary Care Health Center Tiana-Montgat, Montgat, Barcelona, Spain

Keywords: Prevalence of dementiaVascular dementiaResource utilizationCost studyAlzheimer’s dementia

Related Articles for ""
Dement Geriatr Cogn Disord 2005;19:305–315
https://doi.org/10.1159/000084556

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Received: November 01, 2004
Published online: April 29, 2005
Issue release date: May 2005

Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 5

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Objectives: To determine the prevalence of dementia and to measure the monetary impact and health resources utilization of vascular dementia (VD) compared to Alzheimer’s dementia (AD) in persons aged over 64 years in a population setting. Methods: Retrospective, cross-sectional study. In the initial phase, information was obtained on specific clinical characteristics from the subjects with an active diagnosis of dementia. The second phase consisted of a clinical evaluation and validation of the cases. Mini-Mental State Examination was used to assess cognitive impairment. Dementia and its subtypes were determined using established diagnostic criteria. Information was obtained on the use of health care resources (direct costs) and the number of hours devoted by the primary caregiver (indirect costs) for patients with a documented diagnosis of AD or VD within the last 6 months prior to the interview. A multiple logistic regression analysis was performed to correct the model. Results: A total of 6,004 subjects were analyzed, 258 with diagnosis of dementia (overall prevalence: 4.3%). An evaluation was made of 224 patients, and gross prevalence of AD and VD was 2.4 and 1.0%, respectively. Cost per patient per semester was EUR 8,086 for AD and EUR 11,039 for VD (p = 0.016). 85.5% of the cost was attributable to primary caregiver time in AD and 84.4% in VD. Conclusions: The prevalence of AD and VD increases with age. No sociodemographic differences were seen between AD and VD. Costs associated with health care resource and primary caregiver utilization were high, being higher in VD than in AD.

© 2005 S. Karger AG, Basel



Related Articles:

References

  1. Fondo de Investigación Sanitaria: Epidemiología del envejecimiento en España. Madrid, Ministerio de Sanidad y Consumo, 1990.
  2. Casado D: Los efectos del envejecimiento demográfico sobre el gasto sanitario: mitos y realidades. Gac Sanit 2000;15:154–163.
  3. Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW: Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology 1997;49:44–50.
    External Resources
  4. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorenson P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A: Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999;53:1992–1997.
    External Resources
  5. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D’Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer type in Framingham study. Neurology 1992;42:115–119.
    External Resources
  6. Rocca WA, Kokmen E: Frequency and distribution of vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S9–S14.
    External Resources
  7. Leys D, Pasquier F, Parnetti L: Epidemiology of vascular dementia. Haemostasis 1998;28:134–150.
    External Resources
  8. Jorm AF, Jolley D: The incidence of dementia: A meta-analysis. Neurology 1998;51:728–733.
    External Resources
  9. Hebert R, Brayne C: Epidemiology of vascular dementia. Neuroepidemiology 1995;14:240–257.
    External Resources
  10. García García FJ, Sánchez Ayalab MI, Pérez Martín A, et al: Prevalencia de demencia y de sus subtipos principales en sujetos mayores de 65 años: Efecto de la educación y ocupación. Estudio Toledo. Med Clín (Barc) 2001;116:401–407.
  11. Limón Ramírez E, Argimon Pallàs JM, Vila Doménech J, Abos Pueyo T, Cabezas Peña C, Vinyoles Bargalló E: Detección del deterioro cognitivo en población mayor de 64 años: Primera fase del proyecto Cuida’l. Aten Primaria 2003;32:6–12.
    External Resources
  12. Coria F, Gómez JA, Minguez L, Rodríguez-Artalejo F, Clavería LE: Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993;56:973–976.
    External Resources
  13. Bermejo F, Portera A, Gabriel R, et al: The prevalence of dementia and cognitive impairment in three sites in central Spain. A door-to-door study in the elderly. Neuroepidemiology 1997;16:257–270.
    External Resources
  14. Pi J, Olivé JM, Roca J, Masana LL: Prevalence of dementia in a semi-rural population of Catalunya, Spain. Neuroepidemiology 1996;15:33–41.
    External Resources
  15. Bermejo F, Morales JM, Valerga C, Del Ser T, Artolazábal J, Gabriel R: Comparación entre dos versiones españolas abreviadas de evaluación del estado mental en el diagnóstico de demencia. Datos de un estudio en ancianos residentes en la comunidad. Med Clin (Barc) 1999;112:330–334.
    External Resources
  16. Skoog I: Status of risk factors for vascular dementia. Neuroepidemiology 1998;17:2–9.
    External Resources
  17. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002;51:1256–1262.
    External Resources
  18. Moore MJ, Zhu CW, Clipp EC: Informal cost of dementia care: Estimates from the National Longitudinal Caregiver Study. J Gerontol B Psychol Sci Soc Sci 2001;56:S219–S228.
  19. Gutterman EM, Markowitz JS, Lewis B, Fillit H: Cost of Alzheimer’s disease and related dementia in managed medicare. J Am Geriatr Soc 1999;47:1065–1071.
    External Resources
  20. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H: Alzheimer’s disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 2002;58:62–70.
    External Resources
  21. Wimo A, Ljunggren G, Winblad B: Cost of dementia and dementia care: A review. Int J Geriatr Psychiatry 1997;12:841–856.
    External Resources
  22. Boada M, Peña-Casanova J, Bermejo F, Guillén F, Hart WM, Espinosa C, Rovira J: Coste de los recursos sanitarios de los pacientes en régimen ambulatorio diagnosticados de enfermedad de Alzheimer en España. Med Clin (Barc) 1999;113:690–695.
    External Resources
  23. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV: Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: A randomised trial. Lancet 2002;359:1265–1266.
    External Resources
  24. Jonsson L, Lindgren P. Wimo A, Jonsson B, Winblad B: The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer’s disease: A Markov model. Clin Ther 1999;21: 1230–1240.
    External Resources
  25. Wimo A, Winblad B, Engedal K, Soininen H, Verhey F, Waldemer G, Wetterhorn AL, Mastey V, Haglund A, Zhang R, Miceli R, Chin W, Subbiah P: An economic evaluation of donepezil in mild to moderate Alzheimer’s disease: Results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord 2003;15:44–54
    External Resources
  26. Fillit HM, Gutterman EM, Brooks RL: Impact of donepezil on caregiving burden for patients with Alzheimer’s disease. Intl Psychogeriatr 2000;12:389–401.
    External Resources
  27. Fillit HM, Hill J: The costs of vascular dementia: A comparison with Alzheimer’s disease. J Neurol Sci 2002;203–204:35–39.
  28. Kronborg AC, Sogaard J, Hansen E, Kragh-Sorenson A, Hastrup L, Anderson J, Anderson K, Lolk A, Niclson H, Kragh-Sorenson P: The cost of dementia in Denmark: The Odense Study. Dement Geriatr Cogn Disord 1999;10:295–304.
    External Resources
  29. Wimo A, Winblad B: Societal burden and economics of vascular dementia: Preliminary results from a Swedish population-based study. Int Psychogeriatr 2003;15(suppl 1):251–256.
    External Resources
  30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
    External Resources
  31. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637.
    External Resources
  32. Lamberts H, Wood M: Clasificación internacional de la atención primaria CIAP-2. Clasificación de razones de consulta. Barcelona, Masson/SG;1990.
  33. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
    External Resources
  34. Lobo A, Ezquerra J, Burgada FG, Sala JM, Seva A: El Mini-Examen Cognoscitivo (un test sencillo práctico para detectar alteraciones intelectuales en pacientes médicos). Actas LusoEsp Neurol Psiquiatr 1979;7:189–202.
    External Resources
  35. Thompson SG, Barber JA: How should cost data in pragmatic randomized trials be analyzed? BMJ 2000;320:1197–1200.
    External Resources
  36. Vinyoles Bargalló E, Vila Domènech J, Argimon Pallàs JM, Espinàs Boquet J, Abos Pueyo T, Limón Ramírez E: Concordancia entre el Mini-Examen Cognoscitivo y el Mini-Mental State Examination en el cribado del déficit cognitivo. Aten Primaria 2002;30:5–15.
    External Resources
  37. Marcos T, Salamero M, de Azpiazu P, Pujol J, Boget T, Peri JM, Lázaro ML: Patrón de déficit neuropsicológico en la demencia tipo Alzheimer y en la demencia vascular. Med Clin (Barc) 2000;114:566–570.
    External Resources
  38. Frank A, Pohjasvara T, Erkinjuntti T, Barreiro P, Díez-Tejedor E: Trastornos cognitivos relacionados con la isquemia cerebral. Rev Clin Esp 1996;196:51–61.
    External Resources
  39. Ramos-Estébanez C, Hernández Hernández JL, Muñoz Arrondo R, Alonso Valle H: Enfermedad de Binswanger o demencia multiinfarto? Claves diagnósticas en la demencia vascular. Rev Clin Esp 2002;202:7–11.
    External Resources
  40. Aharon-Peretz J, Kliot D, Tomer R: Behavioral differences between white matter lacunar dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 2000;11:294–298.
    External Resources
  41. Finkel SI: Behavioral and psychologic symptoms of dementia. Clin Geriatr Med 2003;19:799–824.
    External Resources
  42. Wilkinson D, Doody R, Helme R, Tautman K, Mintzer J, Kertesz A, Pratt RD, Donepezil 308 Study Group: Donepezil in vascular dementia. Neurology 2003;61:479–486.
    External Resources
  43. Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group: Efficacy and tolerability of donepezil in vascular dementia. Positive results of a 24-week multicentre, international, randomized, placebo-controlled clinical trial. Stroke 2003;34:2323–2330.
    External Resources
  44. Winblad B, Jelic V: Treating the full spectrum of dementia with memantine. Int J Geriatr Psychiatry 2003;18:S41–S46.
    External Resources
  45. Moretti R, Moretti R, Torre P, Antonello RM, Cazzato G, Bava A: Rivastigmine in subcortical vascular dementia: An open 22-month study. J Neurol Sci 2002;203–204:141–146.
  46. López-Arrieta JM, Birks J: Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database of Systematic Reviews. (1):CD000147, 2001.
  47. Sha MC, Callahan CM: The efficacy of pentoxifylline in the treatment of vascular dementia: A systematic review. Alzheimer Dis Assoc Disord 2003;17:46–54.
    External Resources
  48. Hill J, Fillit HM, Futterman R, Shah SN: Healthcare cost of vascular dementia in community-dwelling patients. Neurology 2004;62 (suppl 5): A234 (abstract P03.113).
  49. Kurz A, Hautp M, Pollmann S, Romero B: Enfermedad de Alzheimer: Hay datos de la existencia de subtipos fenomenológicos? Observaciones de un estudio longitudinal. Dementia 1993;3:144–151.
  50. Sicras Mainar A: Impacto económico de las enfermedades y pacientes atendidos en atención primaria. Adaptación de los Grupos Clínicos Ajustados (ACGs) en nuestro medio; Tesis doctoral. Universidad de Barcelona, 2002.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Received: November 01, 2004
Published online: April 29, 2005
Issue release date: May 2005

Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 5

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2005, Vol.19, No. 5-6

May 2005

Article

Recommend This
TOP